Featured Research

from universities, journals, and other organizations

Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment

Date:
September 30, 2002
Source:
National Science Foundation
Summary:
Researchers have found a peptide molecule that triggers celiac sprue - a severe inflammation of the intestine that results from eating wheat and related grains - and propose a treatment strategy that relies on bacterial enzymes to break down the offending molecule in the digestive tract. As many as 1 in every 200 Americans suffers from the condition.

Researchers have found a peptide molecule that triggers celiac sprue - a severe inflammation of the intestine that results from eating wheat and related grains - and propose a treatment strategy that relies on bacterial enzymes to break down the offending molecule in the digestive tract. As many as 1 in every 200 Americans suffers from the condition.

Related Articles


In the September 27 issue of Science, Chaitan Khosla and his coworkers at Stanford University and the University of Norway in Oslo, report disassembling the large, complex mixture of gluten proteins and identifying a single component that triggers the autoimmune response characteristic of celiac sprue.

The study presents, "a combined chemical-physiological-immunological answer to the question 'why is gluten toxic to a person with celiac sprue?,'" said Khosla, whose work is supported by the National Science Foundation (NSF). "If proven correct, the findings will lead to new insights into the causes of celiac sprue, and perhaps certain other types of autoimmune diseases."

The researchers determined that the autoimmune response in people with celiac sprue can be traced to an unusually long molecule - a chain of 33 amino acids - that cannot be broken down by the human digestive system. They immersed the 33-amino acid chain in digestive enzymes derived from bacteria and found that a bacterial enzyme, prolyl endopeptidase, can break the chain into apparently harmless components.

"The technology used to isolate and identify the peptide trigger for celiac sprue, and the enzymology used to neutralize the disease, are marvelous examples of how research into the fundamental understanding of life processes can directly influence human health," said Fred Heineken, program director in NSF's Biochemical Engineering/Biotechnology Program.

Celiac sprue is often diagnosed only after years of painful symptoms. Presently, there is no cure. The only treatment is to completely avoid grains that contain gluten, such as wheat, rye and barley.

The disease usually surfaces in early childhood when intestinal tissue begins to show signs of devastation. Symptoms include chronic diarrhea and an inability to gain weight or grow normally. When the disease arises in adulthood, symptoms can also include fatigue, weight loss, anemia and neurological symptoms. Over time, celiac sprue can lead to overall sickness and even intestinal cancer.

In the small intestine, enzymes from the pancreas initially digest gluten by breaking it into a number of fragments called peptides. In most people, the larger peptides probably work their way down to the lower intestine where they are eaten by microorganisms.

"But in people with celiac sprue, the stable 33-amino acid peptide causes big problems because the molecule is recognized as being a threat to the person's immune system," said Khosla, who also received NSF's Alan T. Waterman Award in 1999. On learning that his family was faced with the illness, Khosla used the award to pursue research on the disease.

Khosla and his coworkers believe the bacterial enzymes, which worked in human tissue cultures as well as intact rats, may result in a simple, oral supplement that can eliminate the harmful effects of gluten. The treatment approach would be similar to enzyme supplements taken orally by people who cannot digest lactose, a sugar found in milk.

Khosla adds that an approved therapy could be as many as 5 to 8 years away, although research is already underway and the treatment should be testable in people within 2 to 3 years.

###

For a static illustration series of the disease process, see: http://www.nsf.gov/od/lpa/news/02/pr0277_image.htm

For more information on Celiac Sprue, see: http://www.nlm.nih.gov/medlineplus/celiacdisease.html

For more information on the Alan T. Waterman Award, see: http://www.nsf.gov/nsb/awards/waterman/waterman.htm


Story Source:

The above story is based on materials provided by National Science Foundation. Note: Materials may be edited for content and length.


Cite This Page:

National Science Foundation. "Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment." ScienceDaily. ScienceDaily, 30 September 2002. <www.sciencedaily.com/releases/2002/09/020927065040.htm>.
National Science Foundation. (2002, September 30). Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2002/09/020927065040.htm
National Science Foundation. "Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment." ScienceDaily. www.sciencedaily.com/releases/2002/09/020927065040.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins